Dietary Manganese

Overview

Manganese is an essential trace mineral that serves as a cofactor for numerous enzymes involved in metabolism, bone development, and antioxidant defense. The body contains approximately 10-20 mg of manganese, primarily in bone, liver, kidney, and pancreas. Dietary manganese deficiency is extremely rare due to its wide availability in foods, but toxicity (primarily from occupational or environmental exposure) is a significant concern causing neurological damage similar to Parkinson's disease.

Biological Functions

• Bone formation: Component of enzymes involved in bone matrix synthesis and cartilage formation
• Antioxidant defense: Manganese superoxide dismutase (MnSOD) in mitochondria neutralizes superoxide radicals
• Carbohydrate metabolism: Activates pyruvate carboxylase and phosphoenolpyruvate carboxykinase in gluconeogenesis
• Amino acid metabolism: Required for arginase (urea cycle)
• Cholesterol synthesis: Activates mevalonate kinase
• Wound healing: Required for proper collagen formation via prolidase
• Neurotransmitter synthesis: Involved in production of neurotransmitters
• Reproductive function: Required for normal reproductive physiology

Health Significance

Despite its essential nature, dietary manganese deficiency has never been conclusively documented in humans eating natural diets. Research interest focuses primarily on two areas: (1) potential protective effects against oxidative stress through MnSOD, and (2) neurotoxicity from excess exposure. Manganese toxicity (manganism) causes a parkinsonian syndrome, making exposure limits critical in occupational settings. The mineral also plays roles in bone health, though clinical significance is less established than for calcium or vitamin D.

Clinical Interpretation Guidelines

When reviewing manganese intake data:

• Recognize deficiency is essentially unknown: From food sources, deficiency doesn't occur
• Focus on excess risk: Most clinical relevance is avoiding toxicity, not preventing deficiency
• Consider occupational exposure: Welders, miners, battery manufacturers at risk
• Assess liver function: Impaired biliary excretion increases toxicity risk
• Review TPN formulation: Patients on long-term TPN require careful manganese dosing
• Note tea consumption: Tea is very high in manganese; heavy tea drinkers may have elevated intake

Deficiency

True manganese deficiency in humans is extremely rare - documented only in experimental settings:

• Research subjects on manganese-depleted diets developed:
  • Dermatitis, skin rash
  • Altered cholesterol and lipid metabolism
  • Impaired glucose tolerance
  • Altered bone/cartilage metabolism
  • Possibly impaired growth (in children)

Conditions that might increase deficiency risk (theoretical):

• Severe malabsorption
• Long-term TPN without manganese
• Very high calcium, iron, or phosphorus intake (competitive inhibition)

Clinical pearl: If manganese deficiency is suspected, look for other nutrient deficiencies first, as isolated manganese deficiency is extraordinarily rare.

Toxicity/Excess

Manganism (chronic manganese toxicity):

• Early symptoms: Psychiatric manifestations - compulsive behavior, emotional lability, hallucinations ("manganese madness")
• Progressive neurological syndrome: Resembles Parkinson's disease
  • Bradykinesia, rigidity
  • Dystonia
  • Gait disturbance (characteristic "cock walk")
  • Tremor (different from PD - less responsive to levodopa)
  • Masked facies

Routes of toxic exposure:

• Occupational inhalation (primary concern): Welding, mining, battery manufacturing
• Contaminated drinking water
• TPN with excessive manganese (especially in liver disease)
• High intake combined with impaired biliary excretion

Risk factors for toxicity:

• Liver disease (impaired biliary excretion is primary elimination route)
• Chronic liver failure/cirrhosis
• Iron deficiency (increases manganese absorption)
• Neonates (immature excretory mechanisms)
• TPN-dependent patients

Diagnosis: Brain MRI shows T1 hyperintensity in basal ganglia (manganese is paramagnetic).

Food Sources

Very high manganese (>1 mg per serving):

• Mussels: 5.8 mg per 3 oz
• Hazelnuts: 1.6 mg per oz
• Pecans: 1.3 mg per oz
• Brown rice: 1.8 mg per cup cooked
• Oatmeal: 1.4 mg per cup
• Pineapple: 1.5 mg per cup

High manganese (0.5-1 mg per serving):

• Whole wheat bread: 0.7 mg per slice
• Sweet potato: 0.5 mg per medium
• Spinach: 0.8 mg per cup cooked
• Tea: 0.5-1.6 mg per cup (varies widely)
• Legumes: chickpeas, lentils
• Tofu: 0.7 mg per 1/2 cup

Moderate sources (0.2-0.5 mg per serving):

• Most fruits and vegetables
• Nuts and seeds
• Whole grains

Note: Tea can be very high in manganese; heavy tea drinkers may obtain substantial manganese from this source.

Absorption Factors

Low bioavailability: Only 1-5% of dietary manganese is absorbed; tightly regulated.

Enhancers:

• Low manganese status (body upregulates absorption when needed)
• Iron deficiency (shared transporters mean more manganese absorbed when iron-depleted)

Inhibitors:

• Iron: High iron intake reduces manganese absorption (competitive)
• Calcium: May reduce manganese absorption
• Phosphorus: Reduces absorption (forms insoluble complexes)
• Phytates: Reduce bioavailability
• Oxalates: May reduce absorption
• Fiber: High fiber intake associated with reduced absorption

Homeostatic regulation: Unlike most minerals, manganese homeostasis is primarily maintained through biliary excretion rather than absorption regulation. This makes liver function critical for manganese balance.

Special Populations

• Liver disease patients: Cannot excrete manganese normally; at high risk for toxicity; TPN manganese must be reduced or eliminated
• Neonates: Immature biliary excretion; higher absorption in gut; TPN-associated toxicity documented
• TPN-dependent patients: Manganese accumulation common; current recommendations suggest reducing or eliminating manganese from TPN
• Iron-deficient individuals: Increased manganese absorption; may accumulate more manganese
• Welders and miners: Occupational exposure risk; respiratory protection important
• Heavy tea drinkers: May have elevated intake, though clinical significance unclear in healthy individuals
• Vegetarians: May have higher intake from plant foods but not clinically concerning

Drug Interactions

• Iron supplements: High-dose iron reduces manganese absorption; conversely, iron deficiency increases manganese absorption and potential toxicity
• Antacids: May affect manganese absorption
• Levodopa: Manganese toxicity can mimic Parkinson's but responds poorly to levodopa
• Quinolone antibiotics: Manganese may reduce absorption; separate by 2 hours
• Tetracyclines: May form complexes with manganese
• Magnesium supplements: May compete for absorption

Caveats & Limitations

• HealthKit captures dietary intake, but toxicity primarily occurs from inhalation exposure (not tracked)
• Dietary deficiency is essentially non-existent; tracking mainly relevant for completeness or research
• Blood manganese levels poorly correlate with body burden
• Whole blood manganese may reflect recent exposure but not tissue accumulation
• Brain MRI (T1 hyperintensity in basal ganglia) is best indicator of excess accumulation
• Tea manganese content varies widely and may not be accurately captured in databases
• Recommendations are Adequate Intake (AI) rather than RDA due to insufficient data for RDA determination
• The very low absorption rate (1-5%) means intake values don't directly predict body manganese status
• Liver function is the primary determinant of manganese toxicity risk, not dietary intake alone